Daiwa Securities Group
ASMB icon

Daiwa Securities Group’s Assembly Biosciences ASMB Stock Holding History

Daiwa Securities Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6
Closed – – 1392
2021
Q3 		$0 Hold
6
– – ﹤0.01% 1315
2021
Q2 		$0 Hold
6
– – ﹤0.01% 1257
2021
Q1 		$0 Hold
6
– – ﹤0.01% 1268
2020
Q4 		$0 Sell
6
-10
-63% -$1.17K ﹤0.01% 1257
2020
Q3 		$3K Buy
16
+4
+33% +$1.01K ﹤0.01% 1113
2020
Q2 		$2K Hold
12
– – ﹤0.01% 1155
2020
Q1 		$2K Hold
12
– – ﹤0.01% 1154
2019
Q4 		$3K Buy
+12
New +$2.21K ﹤0.01% 1143

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Daiwa Securities Group's ASMB Position: Q4 2021 in Review

Daiwa Securities Group sold out of Assembly Biosciences (ASMB) in Q4 2021, closing a stake of 6 shares.

Daiwa Securities Group first reported a position in ASMB in Q4 2019 and held it in 8 quarters. The position peaked at $3K in Q3 2020. 62 funds tracked by Wall St. Rank hold ASMB as of Q4 2021.

  • Daiwa Securities Group reported no remaining Assembly Biosciences position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 6 Assembly Biosciences shares in Q4 2021.
  • Daiwa Securities Group first reported a position in Assembly Biosciences in Q4 2019 and held it in 8 quarters.
  • Daiwa Securities Group's Assembly Biosciences position peaked at $3K in Q3 2020.
  • 62 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.